Early Access — free while we kick the tires
EdgarHawk

Weinhoff Gregory M

Chief Business Officer

Officer
1 filing analyzed · 1 company · Latest 2026-03-13

Companies

Company Buys Sells Direction
Centessa Pharmaceuticals plc CNTA 0 2 Net selling

Activity

March 2026
high
Sell
73,196 shares
$1,927,131
Significance 6/10

CNTA Chief Business Officer Weinhoff sells 73,196 shares for $1.9M amid ongoing losses

Gregory M Weinhoff, Chief Business Officer, executed 2 separate sales totaling 73,196 shares for $1,927,131.05 at blended average price $26.33 on 2026-03-13. The sale reduced his holdings by 52.6%, from 139,121 shares to 65,925 shares. This material reduction in stake occurs in context of significant company stress: Centessa reported net income of $-54,891,000.00 and zero revenue in the latest quarter, with full-year net income negative, while the stock sits -12.0% from its 52-week high despite recent +11.8% 30-day momentum. A sale of this scale by a C-level executive during a period of unprofitability and zero revenue signals reduced executive exposure to company risk, particularly given the magnitude of the position reduction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access